Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Research
Molecular Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

DNA Damage and Cellular Stress Responses

Phosphorylation of Sp1 in Response to DNA Damage by Ataxia Telangiectasia-Mutated Kinase

Beatrix A. Olofsson, Crystal M. Kelly, Jiyoon Kim, Stephen M. Hornsby and Jane Azizkhan-Clifford
Beatrix A. Olofsson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Crystal M. Kelly
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiyoon Kim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen M. Hornsby
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jane Azizkhan-Clifford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1541-7786.MCR-07-0374 Published December 2007
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Sp1, a transcription factor that regulates expression of a wide array of essential genes, contains two SQ/TQ cluster domains, which are characteristic of ATM kinase substrates. ATM substrates are transducers and effectors of the DNA damage response, which involves sensing damage, checkpoint activation, DNA repair, and/or apoptosis. A role for Sp1 in the DNA damage response is supported by our findings: Activation of ATM induces Sp1 phosphorylation with kinetics similar to H2AX; inhibition of ATM activity blocks Sp1 phosphorylation; depletion of Sp1 sensitizes cells to DNA damage and increases the frequency of double strand breaks. We have identified serine 101 as a critical site phosphorylated by ATM; Sp1 with serine 101 mutated to alanine (S101A) is not significantly phosphorylated in response to damage and cannot restore increased sensitivity to DNA damage of cells depleted of Sp1. Together, these data show that Sp1 is a novel ATM substrate that plays a role in the cellular response to DNA damage. (Mol Cancer Res 2007;5(12):1319–30)

Keywords:
  • hydrogen peroxide
  • DNA damage and repair mechanisms
  • Reactive oxygen and carcinogenesis
  • Biomarkers of DNA Damage/Repair, Exposure, and Phenotype
  • Modification of radiation sensitivity

Introduction

Sp1, one of the first gene-specific, metazoan transcription factors identified and cloned, is a ubiquitously expressed essential protein that regulates a variety of cellular and viral promoters (1-5). Sp1 binds to DNA elements known as GC boxes [5′-(G/T)GGGCGG(G/A)(G/A)(G/T)-3′] via three Cys2His2 zinc finger domains, and interacts with the general transcription machinery through two glutamine-rich transactivation domains, designated A and B (Fig. 1 ; refs. 3, 6-9). The majority of TATA-less genes have multiple Sp1 sites in the proximal promoter region, and more than half of expressed genes are TATA-less (10). As such, Sp1 plays a global role in controlling gene expression.

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

Schematic diagram of Sp1. Sp1 has been divided into five domains based on amino acid composition and functional analysis of deletion mutants (42). A and B are transactivation domains (ca. amino acids 85-220 and 261-495, respectively) that have serine/threonine–rich and glutamine-rich segments. SCDs within each of these are shown. The amino acid sequence of the SCD in the A domain is shown above. The C domain (ca. amino acids 496-610) is a highly charged transactivation domain; the DNA-binding domain (amino acids 615-708) contains three zinc finger motifs; and the D domain (ca. amino acids 708-785) mediates Sp1 multimerization and superactivation (76).

Sp1 activity is significantly regulated through posttranslational modifications, including phosphorylation, O-linked glycosylation, acetylation, and sumoylation (11-13). The most studied modification is phosphorylation; Sp1 is phosphorylated by several kinases in vitro, including DNA-dependent protein kinase (DNA-PK), casein kinase II, and cyclin A/cdk2, resulting in both positive and negative effects on transcription (11, 14-16). Responses to a variety of stimuli in a wide array of genes have been ascribed to Sp1, although the underlying mechanisms by which specificity is achieved have generally not yet been elucidated (17, 18). Phosphorylation of Sp1 also coincides with the transition from G0 to G1 (19) and the progression of viral infection (11, 20).

Several studies have also indirectly implicated Sp1 in the cellular response to DNA damage. In human cell lines exposed to ionizing radiation, Sp1 DNA-binding activity has been shown to increase in a transient and reversible manner (21, 22). Also, in cortical neurons, Sp1 DNA binding was shown to increase in response to oxidative stress, and reduction of Sp1 expression by antisense oligonucleotides decreased viability of neurons exposed to oxidative stress (23).

The human genome faces continuous threat of DNA damage by reactive oxygen species generated during aerobic respiration, cellular oxidase activity, and exposure to ionizing radiation (24). Reactive oxygen species–induced DNA damage includes small or bulky modifications to bases and sugars, interstrand and intrastrand cross-links, as well as single-strand breaks and double-strand breaks (DSB; refs. 24, 25). Molecular networks that rapidly sense and repair damage have evolved to maintain genomic stability and ensure cell survival (26).

Most threatening to genomic stability are DSBs, which activate the phosphatidylinositol 3-kinase–related kinases (PIKK), including ataxia-telangiectasia mutated (ATM), DNA-PK, and ATM and Rad3-related (ATR; ref. 27). Cells deficient in PIKKs exhibit accumulated oxidative damage, radiation sensitivity, and impaired cell cycle checkpoint activation in response to DNA damage (28). ATM kinase, which is defective in the hereditary cancer-prone disorder ataxia-telangiectasia (A-T), is activated by DSBs and phosphorylates a variety of proteins involved in the DNA damage response, leading to cell cycle checkpoint activation, DNA repair, altered gene expression patterns, and/or apoptosis (26). Among the ATM substrates are several transcription factors, including p53 (29), BRCA-1 (30), ATF2 (31), cyclic AMP–responsive element binding protein (32), E2F1 (33), and nuclear factor-κB regulators NEMO and IKK (34). ATR, which responds to bulky lesions and single-strand DNA generated by stalled replication forks or the DSB repair process, shares many substrates with ATM. The histone variant H2AX is phosphorylated by ATM, ATR, and DNA-PK over a large region of chromatin surrounding a DSB (35, 36).

Sp1-regulated genes are potentially regulated by ATM, based on gene expression profile comparisons after induction of genotoxic stress in cells encoding either wild-type or nonfunctional ATM (37). ATM function has also been related to Sp1-dependent expression of insulin growth factor-I receptor, as cells deficient in ATM exhibit decreased insulin growth factor-I receptor expression levels compared with normal fibroblasts (38). However, little is still known regarding the regulation of Sp1 in response to DNA damage. Here, we report that Sp1 is a novel substrate for ATM. The kinetics of Sp1 phosphorylation in response to DNA damage parallel those of H2AX, a marker for DSBs. We identify serine 101 of Sp1 as a critical ATM phosphorylation site and show that ATM-dependent phosphorylation of Sp1 modulates cellular survival in response to DNA damage.

Results

Sp1 Is Phosphorylated in Response to H2O2

ATM substrates possess SQ/TQ cluster domains (SCD) and are collectively referred to as SCD proteins (39). The most stringent classification requires a minimum of five SQ/TQ sites within a span of 50 residues with preferred phosphorylation sites generally preceded by a hydrophobic residue such as leucine (40, 41). The Sp1 sequence spanning residues 56 to 102 easily fulfills this criterion, containing five SQ/TQ sites within 47 amino acids (Fig. 1). Sp1 also contains a second SCD domain that meets the less stringent Traven classification (five SQ/TQ within 100 amino acids with a gap of <100 amino acids), possessing 9× SQ/TQ within a span of 147 residues (249-432). Interestingly, these domains reside within Sp1 transactivation domains A and B (42).

Based on the presence of putative SCDs in Sp1 and its reported association with DNA damage, we sought to determine whether Sp1 phosphorylation was stimulated by DNA damage. We initially explored this by treating cells with hydrogen peroxide. H2O2 is a relatively stable reactive oxygen species that diffuses freely into cells, and the resulting increase in intracellular reactive oxygen species production leads to the induction of varied DNA damage, including DSBs (25).

Normal human diploid fibroblasts (NHDF) in mid-log phase were exposed to H2O2, and total cell lysates were prepared after 1 h. Cellular lysates were assayed for Sp1 phosphorylation by immunoblot. Phosphorylation of Sp1 has been reported to induce a shift in electromobility of Sp1 from 95 to 105 kDa (11). Sp1 from untreated cells migrates in SDS-PAGE as a major species of 95 kDa and a minor species of 105 kDa. The shift to 105 kDa was found to be concentration dependent; it is detected in cells exposed to 50 μmol/L H2O2, and becomes the major Sp1 species in cells exposed to 200 μmol/L H2O2 (Fig. 2A, top ). To verify the relationship between Sp1 phosphorylation and H2O2-induced DSB induction, we examined the PIKK-dependent phosphorylation of the histone variant H2AX, which occurs in response to DSB induction (36, 43). Immunoblot analysis of phosphorylated H2AX (γH2AX) revealed a concentration-dependent increase in γH2AX after H2O2 exposure (Fig. 2A, middle). To verify that the shift in Sp1 migration was due to phosphorylation, immunoprecipitated Sp1 from H2O2-treated cells was incubated with phosphatase and analyzed by Sp1 immunoblot. As shown in Fig. 2B, treatment with phosphatase resulted in the loss of the 105 kDa form and a corresponding increase in the 95 kDa form.

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

Dose-dependent modification of Sp1 in response to H2O2 and ionizing radiation. NHDF cells were treated as described followed by SDS-PAGE and immunoblot with the indicated antibody. A. Immunoblot of Sp1 (top), γH2AX (middle), and nucleolin (bottom) prepared from NHDFs exposed to various concentrations of H2O2. After 1 h, cells were harvested directly in SDS sample buffer. B. NHDF cells were exposed to 200 μmol/L H2O2 for 1 h and lysed under nondenaturing conditions. Immunoprecipitated Sp1 was incubated in the presence or absence of 6 units of calf intestinal phosphatase (CIP), followed by immunoblot as described in A. C. NHDFs exposed to 200 μmol/L H2O2 for the indicated times and harvested directly in SDS sample buffer. Immunoblot was done with antibody specific to Sp1, γH2AX, or nucleolin, as indicated. D. NHDF cells were treated with the indicated dose of ionizing radiation and harvested after 15 min. E. NHDF cells were treated with 20 Gy ionizing radiation and harvested at the indicated time points. Immunoblot was done with antibody specific to Sp1 (top), γH2AX (middle), and nucleolin (bottom) as indicated.

We next investigated the kinetics of Sp1 phosphorylation after H2O2 treatment. Extracts of NHDFs were prepared at various time points after exposure to 200 μmol/L H2O2. Phosphorylation was observed as quickly as 15 min posttreatment, reaching peak levels at 1 h (Fig. 2C, top). The change in the phosphorylation of Sp1 was also found to be transient, as the 95 kDa form of Sp1 became the predominant species by 8 h. Immunoblot analysis of γH2AX revealed rapid and transient kinetics of H2AX phosphorylation (corresponding to DSB induction and repair; ref. 44), which paralleled the rapid and transient kinetics of Sp1 phosphorylation (Fig. 2C, middle). These phosphorylation kinetics are consistent with those observed for other ATM substrates (45), suggesting that Sp1 may be a target of the ATM kinase pathway. Changing medium to remove H2O2 had no effect on the level or the kinetics of phosphorylation; therefore, the medium was not changed in subsequent experiments (data not shown).

To further establish a link between DSBs, activation of ATM, and phosphorylation of Sp1, cells were also treated with ionizing radiation. As shown in Fig. 2D and E, exposure of NHDF cells to ionizing radiation induced the phosphorylation of Sp1, with greater radiation doses resulting in a shift to the 105 kDa form. Phosphorylation was detected within 5 min, with the 105 kDa form of Sp1 predominant until ∼2 h after exposure. This transient shift in Sp1 phosphorylation paralleled the transient phosphorylation of H2AX.

The ATM Pathway Mediates the Phosphorylation of Sp1

Oxidative stress and ionizing radiation induce the PIKK family, ATM, ATR, and DNA-PK. To identify the signaling pathway(s) involved in mediating Sp1 phosphorylation in response to DNA damage, we tested the effect of wortmannin and KU55933, a specific ATM inhibitor (46), on peroxide-induced Sp1 phosphorylation. Wortmannin inhibits ATM but not ATR at 20 μmol/L (27), whereas higher doses inhibit ATM, ATR, and DNA-PK. Phosphorylation of Sp1 and H2AX in response to H2O2 was markedly reduced in cells pretreated with 20 μmol/L wortmannin and abolished in cells pretreated with 100 μmol/L wortmannin (Fig. 3A ). Pretreatment with 10 μmol/L KU55933 also prevented Sp1 phosphorylation. These findings indicate that the ATM kinase is the primary mediator of peroxide-induced Sp1 phosphorylation, although other PIKK family members may also target Sp1 to a lesser extent.

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

ATM dependence of H2O2-induced Sp1 phosphorylation. A. Immunoblot of Sp1 (top), γH2AX (middle), and nucleolin (bottom) from NHDFs exposed to 200 μmol/L H2O2 in the presence or absence of 20 or 100 μmol/L wortmannin (Wort.) or 10 μmol/L KU55933 (KU). B. Immunoblot of Sp1 from M059K (DNA-PK+) and M059J (DNA-PK−) glioblastoma cells untreated (−) or exposed to 200 μmol/L H2O2 (+) for 1 h. C. GM03491 (AT wild-type fibroblasts) and GM02052 (AT mutant fibroblasts) were exposed to the indicated concentrations of H2O2 for 1 h, followed by direct lysis in SDS sample buffer, SDS-PAGE, and immunoblot with antibodies to Sp1, γH2AX, or total H2AX, as indicated.

To more directly assess the role of DNA-PK, which phosphorylates Sp1 in vitro (11), in the peroxide-induced phosphorylation of Sp1, we exposed human glioblastoma cell lines with and without functional DNA-PK to H2O2 and found a moderate induction of Sp1 phosphorylation in both cell types (Fig. 3B). These findings suggest that DNA-PK is dispensable for Sp1 phosphorylation in response to H2O2.

Next, we compared Sp1 and H2AX phosphorylation in fibroblasts lacking functional ATM with wild-type fibroblasts from a related donor. In these primary ATM wild-type fibroblasts, Sp1 was found entirely in the 105 kDa form after a 1 h exposure to 25 μmol/L H2O2 (Fig. 3C). H2AX phosphorylation was also induced, reaching maximal levels at 50 μmol/L H2O2. In contrast, the related primary fibroblasts lacking functional ATM did not induce significant Sp1 phosphorylation, and H2AX phosphorylation was detectable only at higher concentrations of H2O2. Taken together, our findings support the notion that the phosphorylation of Sp1 induced by H2O2 is primarily ATM dependent.

Sp1 Is Phosphorylated on S101 in Response to DNA Damage

PIKKs, like other kinases that reportedly phosphorylate Sp1, phosphorylate serine and/or threonine residues (47). As shown in Fig. 4A , Sp1 is primarily phosphorylated on serine(s) after H2O2 exposure. Based on the presence of two distinct SCDs and our phospho–amino acid results, mutations were made in nine serine residues within the two SCDs (36/56/81/85/101/291/296/313/431) of Sp1 either alone or in various combinations. To examine the phosphorylation of these residues in the context of DNA damage, HeLa cells were transfected with expression vectors encoding either HA-Sp1WT or with Ser→Ala substitutions. Most of these mutations had little or no effect on Sp1 phosphorylation in response to DNA damage (data not shown). In contrast, the Sp1S101A mutant remained largely at 95 kDa after H2O2 treatment whereas the HA-Sp1WT shifted to 105 kDa as expected (Fig. 4B).

FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

DNA damage–induced phosphorylation of Sp1 serine 101. A. Phospho–amino acid analysis of Sp1 from NHDFs exposed to 200 μmol/L H2O2 for 1 h in the presence of 32P[Pi]. Immunoprecipitated Sp1 was resolved by SDS-PAGE, transferred to polyvinylidene difluoride membrane, hydrolyzed, spotted on cellulose-coated plates, and separated by two-dimensional electrophoresis. B. Serine 101 was mutated to Ala (S101A) by site-directed mutagenesis of a HA-tagged Sp1 expression construct. HeLa cells were transfected with either the wild-type or mutant expression constructs. Forty-eight hours after transfection, cells were untreated (−) or exposed to 400 μmol/L H2O2 for 1 h (+) before lysis under nondenaturing conditions. Lysates were separated by SDS-PAGE, transferred to nitrocellulose, and immunoblotted with HA-specific antibody. C. NHDFs were treated for 1 h with 200 μmol/L H2O2 (+) or untreated (−), followed by lysis, SDS-PAGE, and immunoblot with polyclonal antibody to Sp1 (pAb581) or γSp1101. D. NHDFs were depleted of endogenous Sp1 by siRNA [bottom, immunoblot of Sp1 from cells 72 h posttransfection with Sp1 siRNA or nontargeting (NT) siRNA]. Seventy-two hours after siRNA transfection, cells were transfected with HA-Sp1WT or HA-Sp1S101A. Forty-eight h after transfection, cells were untreated (−) or exposed to 200 μmol/L H2O2 for 1 h (+), followed by direct lysis and immunoblot with the indicated antibodies.

To verify that S101 is phosphorylated in response to DNA damage, a phosphospecific antibody that specifically recognizes phosphorylated S101 was generated by 21st Century Biochemicals, Inc. In immunoblot experiments, this antibody, designated γSp1101, detects Sp1 in cells treated with H2O2 but does not detect Sp1 in untreated cells (Fig. 4C). Further, in cells depleted of endogenous Sp1 by double-stranded small interfering RNA (siRNA) oligonucleotides targeting the 3′ untranslated region (UTR) of Sp1 mRNA, exogenously expressed HA-Sp1WT is detected by γSp1101, whereas Sp1S101A is not (Fig. 4D). Taken together, these data strongly support that S101 of Sp1 is phosphorylated in response to DNA damage.

Sp1 Depletion Renders Cells More Sensitive to DNA Damage

GC-rich regions of the genome are unusually sensitive to DNA damage by alkylating agents and represent more open regions of chromatin (48-51). Because Sp1 binds to GC boxes, we sought to determine the effect of Sp1 depletion on the induction of DSBs by ionizing radiation. NHDF cells were transfected with Sp1 siRNA, followed by treatment with low-dose ionizing radiation (0.5 Gy). At this dose, foci of γH2AX around DSB sites are visible by indirect immunofluorescence (35). Cells were processed for immunofluorescence 10 min, 4 h, and 16 h after exposure. As shown in Fig. 5A , γH2AX foci were observed 10 min and 4 h after exposure of cells depleted of Sp1 with siRNA to ionizing radiation, whereas foci were much less frequent and fewer in number in cells transfected with a nontargeting control siRNA. Foci were counted in at least 30 cells in a blinded fashion. An average of seven foci per cell were observed 10 min after treatment of cells depleted of Sp1 compared with less than two foci for the control cells (Fig. 5B). Analysis of data by Student's t test revealed that the number of γH2AX foci observed in Sp1-depleted cells was significantly higher compared with cells transfected with nontargeting siRNA (P < 0.01 at 10 min and P = 0.024 at 4 h). As shown in Fig. 5C, γH2AX foci in U2OS were observed at 10 min, 4 h, and 16 h after exposure of cells depleted of Sp1 with siRNA to ionizing radiation with a similar pattern as seen in NHDF. Fewer foci were observed in cells transfected with nontargeting control siRNA. Foci were counted in at least 30 cells in a blinded fashion. An average of 36 foci per cell were observed 10 min after treatment of cells depleted of Sp1 compared with 14 foci for the control cells; U2OS cells depleted of Sp1 still maintained a high number of foci (an average of 10) 16 h after treatment, whereas the U2OS cells transfected with nontargeting control siRNA had an average of two foci after 16 h (Fig. 5D). The number of γH2AX foci observed in Sp1-depleted cells was significantly higher (P < 0.001) than in cells exposed to a nontargeting siRNA at all time points. Taken together, these data suggest that Sp1 may play a role in protecting DNA from the induction of DSBs by ionizing radiation.

FIGURE 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 5.

Effect of Sp1 on formation of ionizing radiation–induced γH2AX foci. NHDF (A and B) or U2OS (C and D) cells were transfected with siRNA directed against the 3′ UTR of Sp1 or nontargeting control siRNA as described in Materials and Methods. Seventy-two hours after transfection, cells were exposed to 0.5 Gy ionizing radiation and at the indicated time points after ionizing radiation exposure, cells were processed for indirect immunofluorescence and probed with antibodies to γH2AX. A and C. Representative cells from each group. B and D. Quantitative analysis. Foci of γH2AX were counted in at least 30 cells. Columns, average number of foci per cell; bars, SE. *, significant differences of P < 0.01 at 10 min and P = 0.024 at 4 h in B and P < 0.001 at all time points in D.

To further examine whether Sp1 modulates the cellular response to DNA damage, the effect of Sp1 on cell survival after exposure to ionizing radiation or H2O2 was assessed by clonogenic survival assays in NHDF or U2OS cells that were depleted of Sp1 using siRNA. Transfection of double-stranded siRNA into NHDF and U2OS cells resulted in a 90% knockdown of Sp1 protein levels 3 days posttransfection (Fig. 6, inset ). Cell morphology and growth were not significantly perturbed by Sp1 siRNA (data not shown). Cells depleted of endogenous Sp1 exposed to 50 or 100 μmol/L H2O2 showed decreased colony formation relative to cells transfected with a nontargeting siRNA (Fig. 6A and C). Similarly, cells depleted of Sp1 also showed decreased colony formation after exposure to 0.5, 1, 2.5, or 5 Gy ionizing radiation relative to a nontargeting control siRNA (Fig. 6B and D).

FIGURE 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 6.

Sp1 knockdown decreases cell survival after H2O2 or ionizing radiation exposure. NHDFs (A and B) or U2OS (C and D) were transfected with siRNA directed against the 3′ UTR of Sp1 or nontargeting control siRNA as described in Materials and Methods. Seventy-two hours after siRNA transfections, cells were exposed to 50 or 100 μmol/L H2O2 (A and C) or 0.5, 1, 2.5, or 5 Gy ionizing radiation (B) or 0.5 or 2.5 Gy ionizing radiation (D) followed by clonogenic survival assay. Western blots below each graph show Sp1 (top) and nucleolin (bottom) levels 72 h after transfection with Sp1 or nontargeting control siRNA in NHDF and U2OS cells.

To determine whether the decreased cell viability detected by the colony survival assays resulted from an increase in apoptosis, terminal deoxyribonucleotide transferase–mediated nick-end labeling (TUNEL) assays were done in U2OS cells treated with siRNA compared with nontargeting control siRNA. U2OS cells were used in this assay because fibroblasts do not normally undergo apoptosis but enter senescence. U2OS cells were transfected with siRNA, followed by treatment with 400 μmol/L H2O2 for 4 h. Cells were processed for immunofluorescence and, as shown in Fig. 7A , the number of TUNEL-positive cells (indicative of fragmented DNA) after treatment was significantly increased in cells depleted of Sp1. Quantification of these results revealed that 76% of the cells depleted of Sp1 with siRNA are TUNEL positive after H2O2 treatment, compared with 10% of cells transfected with nontargeting control siRNA (Fig. 7B). The significant (P < 0.01) increase in DNA fragmentation in cells depleted of Sp1 with siRNA corresponds to the increase in γH2AX foci and the decrease in cell viability resulting from depletion of Sp1 (Figs. 5 and 6).

FIGURE 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 7.

Sp1 knockdown increases cell death after H2O2 exposure. U2OS were transfected with siRNA directed against the 3′ UTR of Sp1 or nontargeting control siRNA as described in Materials and Methods. Seventy-two hours after siRNA transfections, cells were exposed to 400 μmol/L H2O2 followed by TUNEL assay after 4 h. A. Representative cells from each group. B. Quantitative analysis. At least 300 cells were counted in each treatment group. Columns, average number of foci per cell; bars, SE. *, a significant difference (P < 0.001).

Experiments were next done to determine whether the increased sensitivity of cells after Sp1 depletion by RNA interference was related to Sp1 phosphorylation. Colony survival assays were done in U2OS cells, which can be more effectively transfected with exogenous Sp1 (∼60%) compared with fibroblasts. Sp1 is phosphorylated on serine 101 in U2OS cells exposed to varying concentrations of H2O2 in a manner similar to NHDF as seen by γSp1101 antibody (Fig. 8B ). As shown in Fig. 8A, Sp1 depletion by Sp1 siRNA inhibited colony survival of U2OS cells in response to H2O2 in a concentration-dependent manner. Expression of wild-type Sp1 restored survival to the level observed with nontargeting RNA interference, rescuing cells from the effect of Sp1 depletion at every concentration of H2O2 tested. In contrast, expression of Sp1S101A (which is not phosphorylated in response to damage) failed to rescue cells from the effects of Sp1 depletion on survival. Equivalent expression of wild-type Sp1 and Sp1S101A is shown in Fig. 8B. These results show that the phosphorylation of Sp1 on serine 101 by ATM plays an important role in modulating the cellular response to DNA damage.

FIGURE 8.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 8.

Sp1 complementation assay. A. U2OS cells were transfected with nontargeting control or Sp1 siRNA. Seventy-two hours after siRNA transfection, cells were transfected with Sp1WT or Sp1S101A. Forty-eight hours after transfection, cells were exposed to the indicated amount of H2O2 for 1 h. Cells were then plated at a density of 300 cells per 60-mm dish. After 11 d, discrete colonies were stained with crystal violet and counted in a blinded manner. Data are expressed relative to the number of colonies in the nontreated cells receiving the same DNAs. B. U2OS cells were exposed to the indicated concentrations of H2O2 for 1 h and harvested directly in SDS sample buffer. Immunoblot was done with antibody specific to HA.11 and γSp1101. Bottom inset, Western blot shows Sp1 (top) and nucleolin (bottom) levels 72 h after transfection with Sp1 or nontargeting control siRNA.

Discussion

These studies have established that Sp1, a global regulator of gene expression, is a target of the ATM-dependent DNA damage response pathway. Although the precise role of Sp1 phosphorylation in the DNA damage response is not entirely clear, the parallel kinetics of phosphorylation/dephosphorylation with H2AX, the increased sensitivity to DNA-damaging agents in cells depleted of Sp1, and the rescue of this sensitivity with wild-type Sp1 but not the phosphorylation site mutant, Sp1S101A, suggest that Sp1 is an early target of the DNA damage response pathway and may play a role in modulating the cellular response to DNA damage.

Sp1 is a member of the Sp/KLF family of transcription factors, which bind GC elements in a wide array of promoters (17). These factors compete for binding to the same elements depending on cellular conditions (22, 52-54). Sequence comparison among the Sp proteins [Sp2 (accession no. Q02086), Sp3 (accession no. Q02447), and Sp4 (accession no. Q02446)] reveals that Sp1 is the only member to contain consensus SCD (e.g., moreover, SCDs were not found in other KLF family members). Given that Sp1 is the only KLF family member containing SCDs, other KLF family members likely cannot compensate for the unique role of Sp1 in the DNA damage response, suggesting that this may explain the essential role of Sp1 accounting for the embryonic lethality of Sp1 knockout mice (4).

Identification of SCDs within the transactivation domains of Sp1 suggested that it was a likely substrate of PIKKs. Use of specific inhibitors and kinase-deficient cells revealed that treatment of cells with H2O2 or ionizing radiation induced ATM-dependent phosphorylation of Sp1. Our data do not rule out the possibility that other kinases may contribute to the overall phosphorylation. For example, phosphorylation of Sp1 by ATR is suggested by the delayed phosphorylation in the presence of the specific ATM inhibitor, KU55933, as well as by the phosphorylation at higher H2O2 concentrations in AT mutated cells. Kinases downstream of ATM (e.g., Chk2) may also contribute to damage-induced phosphorylation of Sp1. Although DNA-PK has been reported to phosphorylate Sp1 in vitro (11) and in cells exposed to etoposide (55), the finding that Sp1 phosphorylation in response to H2O2 was not affected by the absence of DNA-PK suggests that it may not be involved (Fig. 3B).

Serine 101 is within one of the SCDs and mutation of this site to alanine abolishes peroxide-induced phosphorylation of Sp1. Although it is likely that other sites are phosphorylated in response to DNA damage, the significant reduction in phosphorylation in the S101A mutant suggests that S101 may serve to signal phosphorylation of additional Ser residues. Moreover, mutation of serine 101 to glutamic acid (S101E) to mimic phosphorylation results in a phosphorylation-dependent shift in the mobility of Sp1 from 95 to 105 kDa even in the absence of damage (data not shown).

Recently, a large-scale proteomic search based on the presence of previously identified SQ motifs phosphorylated by ATM revealed over 700 proteins phosphorylated by ATM and ATR, including many previously unknown ATM/ATR substrates (56). Proteins identified in this screen were found to modulate the number of spontaneously formed DSBs, levels of γH2AX after ionizing radiation exposure, cell cycle checkpoint activation, or levels of homologous recombination. These findings indicate that large networks of proteins are involved in modulating cellular survival after DNA damage. Interestingly, Sp1 as well as other transcription factors that have been shown to be ATM substrates were not identified in this study. The failure to detect these substrates may have resulted from the use of trypsin cleavage before mass spectroscopy. In our experience and according to mass spectrometry protein cleavage prediction programs, such as Protein Prospector,1 fragments containing the consensus ATM SQ/TQ sites including S101 are more then twice the size needed for efficient detection by mass spectrometry after cleavage of Sp1 with trypsin.

Depletion of factors involved in the DNA damage response results in increased sensitivity to DNA damage, as shown in cells lacking functional ATM kinase or BRCA1 (57-60), as well as in cells deficient in NBS1, FANC-A, FANC-D, and MRE11 (61-67). Our results show that, like many other ATM/ATR substrates, depletion of Sp1 renders cells more sensitive to the effects of DNA damage. Moreover, the sensitivity is mediated by the phosphorylation of Sp1, as the phosphorylation site mutant failed to rescue cells depleted of endogenous Sp1. Although the mechanism whereby Sp1 modulates cell survival remains to be determined, we find an increased number of DSBs when cells deficient in Sp1 are exposed to ionizing radiation (Fig. 5), which suggests that the lack of Sp1 may leave GC-rich regions of the genome more vulnerable to DSBs.

The DNA damage response involves ATM-dependent changes in gene expression patterns (67-69). When cells with and without functional ATM were exposed to ionizing radiation, UV, and t-butyl hydroperoxide, several Sp1-regulated genes were found to be ATM dependent (37, 70). Studies comparing the expression of the insulin growth factor receptor-I in normal fibroblasts and AT-mutated fibroblasts showed decreased levels of insulin growth factor-I receptor in AT-mutated cells and identified Sp1 as a potential mediator between ATM and insulin growth factor-I receptor expression (38). In addition, ATM is induced by infection of cells with herpes simplex virus-1 and SV40 (71, 72), which also induce Sp1 phosphorylation (11, 20). Kim and DeLuca have shown that phosphorylated Sp1 purified from herpes simplex virus-1–infected cells has decreased ability to activate transcription in in vitro transcription assays and that the kinetics of the phosphorylation correlate with the expression of Sp1-independent viral late genes, suggesting a viral-mediated temporal regulation of gene expression. While this article was in review, another group reported that the phosphorylation of Sp1 during herpes simplex virus-1 infection was at S101 and was also seen in response to ionizing radiation (73). Together with our findings, Sp1 is a target of the ATM pathway. Moreover, phosphorylation of Sp1 by ATM may modulate Sp1-dependent gene expression (20). Studies are under way to examine the effect of Sp1 phosphorylation on Sp1-dependent gene expression using the S101A mutant.

This study places Sp1, once thought to be an unregulated, constitutive transcriptional activator, as a factor involved in the response to DNA damage. Sp1 joins a growing number of transcription factors targeted immediately after DNA damage and identification of S101 as a critical phosphorylation site leaves us poised to establish its role. Clearly, more work is needed to fully understand the role of Sp1 in the DNA damage response; however, we have provided evidence that it is a substrate of ATM and that it is involved in the response evidenced by increased sensitivity to DNA damage. This work further extends the role of Sp1 beyond that of a constitutive transcription factor and provides evidence for a significant role in the response to DNA damage. Whether the phosphorylation of Sp1 by ATM induces changes in chromatin structure that affect sensitivity to DNA damage and/or gene expression or whether it has a more direct role in modulating gene expression requires further study.

Materials and Methods

Cell Lines

NHDFs (Clonetic) were cultured in DMEM (Cellgro, Mediatech, Inc.) with 10% fetal bovine serum (FBS, Equitech), 2 mmol/L l-glutamine (Cellgro, Mediatech), and 100 units/mL penicillin, and 100 μg/mL streptomycin (Pen/Strep, Sigma) in a 37°C humidified atmosphere of 10%CO2, 90% air. ATM untransformed fibroblasts from a clinically affected 15-year-old female homozygous for the 103C>T transition in exon 5 of the ATM gene (GM02052, Coriell) and untransformed fibroblasts from a clinically unaffected sister of the proband (GM03491, Coriell) were cultured in MEM with Eagle-Earle salts (MEM, Cellgro, Mediatech) containing 15% FBS (Equitech), 2 mmol/L l-glutamine, 1× nonessential amino acids (Sigma), and Pen/Strep at 37°C in a humidified atmosphere of 5% CO2, 95% air. The M059J human glioblastoma cell line (American Type Culture Collection) lacks DNA-dependent protein kinase activity whereas the M059K human glioblastoma cell line (American Type Culture Collection) from the same donor expresses normal levels of active DNA-dependent protein kinase. These cells were cultured in DMEM/Ham's F-12 50/50 mix (Cellgro, Mediatech) with 10% FBS (Equitech), 2 mmol/L l-glutamine, and Pen/Strep at 37°C in a humidified atmosphere of 10%CO2, 90% air. The U2OS human osteosarcoma cell line (kindly provided by M. Murphy, Fox Chase Cancer Center, Philadelphia, PA) were maintained in DMEM containing 10% FBS, 2 mmol/L l-glutamine, and Pen/Strep at 37°C in a humidified atmosphere of 10% CO2, 90% air. Human papilloma virus–transformed cervical epithelial cells (HeLa, University of North Carolina Lineberger Cancer Center Cell Culture Facility) were cultured in DMEM (Cellgro, Mediatech) containing 10% FBS (Equitech), 2 mmol/L l-glutamine (Cellgro, Mediatech), and Pen/Strep at 37°C in a humidified atmosphere of 5% CO2, 95% air.

Cell Treatments

H2O2 (30% w/w solution; Calbiochem) was added directly to the medium of exponentially growing cells. To deliver an accurate volume, it was sometimes necessary to dilute the H2O2 in sterile water by a factor of 10 or 100 immediately before adding it to the cell medium. Medium was not changed after H2O2 treatment. For cells additionally exposed to wortmannin (Biomol), this agent was dissolved in DMSO (10 mmol/L stock, 20 or 100 μmol/L final) and added to the cell medium 5 to 15 min before the addition of H2O2. KU55933 (kindly provided by Graeme Smith of KuDOS Pharmaceuticals Ltd.) was dissolved in DMSO (10 mmol/L stock, 10 μmol/L final) and added 1 h before addition of H2O2. For the experiments using ionizing radiation, exponentially growing cells were irradiated at room temperature using an X-ray source (dose rate of 3 Gy/min).

In vitro Phosphatase Assay

Sp1 was immunoprecipitated from NHDFs exposed to 200 μmol/L H2O2 for 1 h. Cells were lysed in ice-cold immunoprecipitation buffer (50 mmol/L Tris 8.0, 0.5% Igepal, 120 mmol/L NaCl, 1.5 mg/mL aprotinin, 0.01 mg/mL leupeptin, 1 mmol/L phenylmethylsulfonyl fluoride). The chromatin was sheared by passing the lysate several times through a tuberculin syringe, and the lysate was cleared by centrifugation at 14,000 × g for 10 min at 4°C. Approximately 500 μg of lysate were mixed with 8 μg Sp1-specific antibody (PEP-2G, Santa Cruz Biotechnology). The mixture was incubated for 1 h at 4°C with rocking, followed by the addition of protein G slurry (Sigma). After 2 h incubation at 4°C with rocking, immunocomplexes were washed thrice in immunoprecipitation buffer and incubated with or without 6 units calf intestinal alkaline phosphatase (Promega; 1 unit/μL) for 40 min at 30°C, according to the manufacturer's instructions. The reaction was stopped by centrifuging the protein G slurry, removing the supernatant, and adding 2× SDS sample buffer to the immune complexes. Sp1 electrophoretic mobility was detected by immunoblot using a Sp1-specific antibody.

Phospho–Amino Acid Analysis

NHDFs were plated at 1.5 × 106 cells in a 10-cm dish 24 h before the experiment. On the day of the experiment, the cells were washed thrice in 1× HBS. The cells were then incubated in phosphate-free DMEM supplemented with 10% dialyzed FBS for 2 h at 37°C. NHDFs were then exposed to 200 μCi 32P-Pi (NEN) per milliliter of medium for 2.5 h. NHDFs were then treated with 200 μmol/L H2O2 for an additional hour. The cells were washed once in 1× HBS and then harvested in 400 μL of lysis buffer [10 mmol/L Tris (pH 7.4), 1 mmol/L DTT, 1% SDS]. The lysate was boiled at 95°C for 6 min and 800 μL of cold immunoprecipitation buffer was added [15 mmol/L Tris (pH 7.4), 230 mmol/L NaCl, 1.5% Triton X-100, 0.75% Igepal, 7.5 mmol/L EDTA, 0.02 mg/mL leupeptin, 2 mg/mL pepstatin A, 3 μg/mL aprotinin, 2 mmol/L phenylmethylsulfonyl fluoride, 15 mmol/L NaF, and 3 mmol/L NaVO4]. The lysate was sheared with a tuberculin syringe and centrifuged at 14,000 × g for 15 min at 4°C. The supernatant was transferred to a new tube and rocked with Sp1-specific antibody (pAb581, polyclonal, made at Roswell Park Cancer Institute against amino acids 524-543) for 30 min at 4°C. Twenty-five microliters of protein A:Sepharose beads (Sigma) were added and rocked overnight at 4°C. Beads were washed thrice in 0.5 mL radioimmunoprecipitation assay buffer. Samples were boiled in 30 μL 2× SDS sample buffer for 5 min at 90°C. Samples were resolved on 6.5% SDS-PAGE and transferred to polyvinylidene difluoride membrane. Blots were exposed to film overnight. The band corresponding to the signal on the developed film was cut from the polyvinylidene difluoride membrane. The excised membrane was washed in methanol once and four times in water and transferred to a tube containing 200 μL of boiling HCl (Sigma) and boiled for 1 h at 110°C. Supernatant was transferred to a new tube and dried and resuspended in 5 μL buffer (pH 1.9; 50 mL formic acid, 156 mL glacial acid, 1794 mL distilled H2O) and with 5 μL phospho–amino acid standards (1 mg/mL phospho-serine, phospho-threonine, phospho-tyrosine) added. The sample was added to a nitrocellulose plate (EM Science) in 0.5 μL drops and run in Hunter Thin Layer Peptide Mapping System at 1.5 kV for 25 min. After air drying the plate, it was rewet in buffer (pH 3.5; 100 mL glacial acetic acid, 10 mL pyridine, 1890 mL dH2O) and the plate was turned 90° counterclockwise and run in Hunter Thin Layer Peptide Mapping System at 1.3 kV for 20 min. The plate was allowed to air dry after the second run then sprayed with ninhydrin and baked at 65°C for 10 min to visualize standards. The plate was exposed to a phosphoscreen for 24 h.

Site-Specific Mutagenesis

Point mutations of various SQ sites located in the transactivation domains of Sp1 were made using the QuikChange Site-Directed Mutagenesis kit (Stratagene). The amino acid numbers are based on Sp1 sequence containing 785 amino acids (National Center for Biotechnology Information accession number NM_138473, NP_612482). The following primer sequences were used:

  • S101A: 5′-CCTCACAGCCACACAACTTGCACAGGGTGCCAATGGC-3′;.

  • S101E: 5′-GACCTCACAGCCACACAACTTGAACAGGGTGCCAATGGCTGG-3′;.

  • S291A: 5′-GCAGCTCTGGGGCCCAGGAGAGTGGC-3′;.

  • S296A: 5′-CCCAGGAGAGTGGCGCACAGCCTGTCACC-3′;.

  • S36A: 5′GGTGGTGGTGCCTTTGCACAGGCTCGAAGTAGC-3′;.

  • S56A: 5′-GGAGGGCAGGAGGCCCAGCCATCCC-3′;.

  • S313A: 5′-GCCAGCTTGGTATCAGCACAAGCCAGTTCC-3′;.

  • S431A: 5′-CCTTTACAACTCAAGCCATCGCCCAGGAACCC-3′;.

  • S81,85A: 5′-GAACAGCAACAACGCCCAGGGCCCGGCTCAGTCAGGGGGAACAGGTGAGC-3′.

QuikChange PCR was done on Sp1 cDNA with a COOH-terminal HA-tag subcloned into the pFLAG-CMV2 plasmid (Sigma). PCR reactions were prepared according to the manufacturer's specifications. Recombinant colonies were screened for the appropriate mutation by fluorescent sequencing.

RNA Interference

We designed RNA oligonucleotides targeting the 3′ UTR of Sp1 mRNA. The two targets are 3′ UTR3429UCAGUGGAAUUGUACAAGA3447 (siSp1 2) and 3′ UTR4974GGAAUCUUCUCCAGUAUGA4992 (siSp1 1) of Sp1 mRNA (NCBI accession no. NM_138473). These were tested separately and together and 200 pmol (100 pmol of each siRNA) were used together to transfect 2 × 105 cells per well of a six-well plate in all experiments shown. As a nontargeting control siRNA, we altered siSp1 1 by one nucleotide: GGAAUCUUCUACAGUAUGA. This change created a siRNA that did not significantly reduce Sp1 levels. These double stranded RNA oligonucleotides were synthesized by Dharmacon.

Transfections

NHDF, HeLa, or U2OS cells were transfected with wild-type and mutant Sp1 constructs in pFLAG-CMV2 using Metafectene Pro (Biontex) or Lipofectamine 2000 (Invitrogen) transfection reagent according to the manufacturers' instructions. Approximately 48 h after transfection, cells were either exposed to H2O2 for 1 h or were left untreated. Cells were then harvested by direct lysis in 2.0× SDS sample buffer. For siRNA transfections, NHDF or U2OS cells were plated in six-well plates 24 h before transfection. Transfections were carried out using Oligofectamine Reagent (Invitrogen Corp) according to the manufacturer's instructions. Seventy-two hours after transfection, cells were assayed for the presence of Sp1 by immunoblot.

Immunoblot

Protein expression and modification were analyzed by immunoblot. Total cell lysates were prepared by either direct lysis of washed cells in 1.5× SDS sample buffer, or by nondenaturing cell lysis in 20 mmol/L Tris-HCl (pH 7.8), 100 mmol/L NaCl, 0.5% Igepal, 1 mmol/L EDTA, 1.5 μg/mL aprotinin, 10 μg/mL leupeptin, 1 mmol/L DTT, 1 μg/mL pepstatin A, 1 mmol/L phenylmethylsulfonyl fluoride, 5 mmol/L NaF, 5 mmol/L β-glycerophosphate, and 0.1 mmol/L Na3VO4 (each from Sigma). Cells lysed under nondenaturing conditions were incubated at 0°C to 4°C for 15 to 20 min and then transferred to microcentrifuge tubes. Chromatin was sheared by passing the lysate three to four times through a tuberculin syringe. Insoluble material was cleared by centrifugation at 14,000 × g for 10 min at 4°C. Following protein quantitation by the Bradford method, 10 to 20 μg of protein were used for SDS-PAGE. Samples were electrophoresed at 150 V in Tris glycine SDS running buffer [25 mmol/L Tris, 192 mmol/L glycine, 0.1% SDS (pH 8.3)]. Following electrophoresis, proteins were transferred to nitrocellulose membrane (Schleicher and Schuell) in Tris acetate transfer buffer. Immunoblot was done by blocking membranes in 5% nonfat dried milk (Carnation) in PBS with 0.1% Tween 20 (PBST) followed by incubation with primary antibodies in 5% nonfat dried milk in PBST 14 to 18 h at 4°C with rocking with all antibodies, except γSp1101 in which bovine serum albumin (5%, Fraction V, Fisher Scientific) was used. Primary antibodies used for immunoblot include rabbit polyclonal antibodies specific for Sp1 (pAb581, made at Roswell Park Cancer Institute against amino acids 524-543), mouse monoclonal antibodies specific for γH2AX [phospho-histone H2AX (serine 139), clone JBW301; Upstate], total H2AX (Upstate), α-tubulin (Sigma), nucleolin (C23; Santa Cruz Biotechnology), and HA (HA.11; Covance). Phospho-Sp1S101 was made by 21st Century Biochemicals, Inc. Acetyl-DLTATQL[pS]QGANGK-amide produced a high-affinity polyclonal antibody that specifically recognized phosphorylated S101; this antibody was designated γSp1101. The primary antibodies were detected with horseradish peroxidase–conjugated goat anti-rabbit IgG (Santa Cruz Biotechnology) or goat anti-mouse IgG (Santa Cruz Biotechnology). Chemiluminescence was developed using Super Signal (Pierce).

Cytotoxicity Assays

Clonogenic assays were done in NHDFs as follows: 2.0 × 105 NHDFs were seeded in 30-mm dishes for transfection with RNA interference. Seventy-two hours after transfection, cells were exposed to 50 to 100 μmol/L H2O2 or 0.5 to 5 Gy ionizing radiation. One hundred NHDFs or 300 U2OS cells were seeded onto 60-mm dishes after exposure to H2O2 or ionizing radiation. The cell medium was changed every 3 days. Colonies, which formed between 18 and 24 days after plating for NHDF and 11 days after plating for U2OS, were fixed and stained with a crystal violet solution (0.5% in 20% ethanol) and then counted. Assays were done in triplicate. Clonogenic survival assays in U2OS cells were done as follows: 4.0 × 105 U2OS were seeded in 30-mm dishes and transfected with RNA interference. These cells were trypsinized and counted 72 h after RNA interference transfection and then transfected with wild-type or S101A mutant Sp1 constructs. Cells were exposed to 25 to 200 μmol/L H2O2 48 h after transfection. Three hundred cells were reseeded onto 60-mm dishes 2 h after exposure to H2O2. The cell medium was changed every 3 days. Colonies, which formed 11 days after plating, were fixed and stained with a crystal violet solution (0.5% in 20% ethanol), and then counted. Assays were done in triplicate. Data were analyzed by Student's t test.

Immunofluorescence

NHDF or U2OS cells were plated onto glass coverslips 24 h before treatment with 0.5 Gy ionizing radiation. The in situ cell fractionation protocol for NHDF was adapted from ref. 74 with modifications. Briefly, cells were washed in ice-cold PBS twice and incubated in ice-cold cytoskeleton buffer [10 mmol/L PIPES (pH 6.8); 100 mmol/L NaCl, 300 mmol/L sucrose, 3 mmol/L MgCl2, 1 mmol/L EGTA] for 5 min, followed by incubation in ice-cold cytoskeleton stripping buffer [10 mmol/L Tris-HCl (pH 7.4), 10 mmol/L NaCl, 3 mmol/L MgCl2, 1% v/v Tween 40, 0.5% sodium deoxycholate] for 5 min. Cells were then washed in PBS, and fixed using Streck Tissue Fixative (Streck Laboratories) with 50 mmol/L EDTA (pH 5.7; ref. 75) for 30 min at room temperature. Cells were washed thrice in room temperature PBS and blocked in 10% FBS-PBS for 1 h at room temperature. Primary antibody, mouse monoclonal γH2AX (serine 139, Upstate Biotechnology), diluted 1:500 in 5% FBS-PBS solution was added and cells were incubated in this solution for 1 h. Cells were washed in PBS five times followed by the addition of secondary antibody, AlexaFlour594 donkey anti-mouse antibody, diluted 1:1,000 in 5% FBS-PBS for 2 h in the dark. Cells were washed five times with PBS. U2OS cells were washed in ice-cold PBS twice and fixed in 2% paraformaldehyde in PBS for 15 min at room temperature. Cells were washed twice in PBS at room temperature and then incubated in 0.5% Triton X-100 in PBS for 1 h at room temperature. Cells were washed thrice in room temperature PBS and blocked in 1% FBS-PBS for 1 h at room temperature. Primary antibody, mouse monoclonal γH2AX (serine 139, Upstate Biotechnology), diluted 1:500 in 1% FBS-PBS solution was added and cells were incubated in this solution for 1 h. Cells were washed in PBS five times followed by the addition of secondary antibody, AlexaFlour594 donkey anti-mouse antibody, diluted 1:1,000 in 1% FBS-PBS for 2 h in the dark. Cells were washed five times with PBS. Slides were mounted using Vectashield mounting medium containing 4′,6-diamidino-2-phenylindole (Vector Labs).

TUNEL Assay

U2OS cells were plated onto glass coverslips 24 h before treatment with 400 μmol/L H2O2. Cells were incubated for 4 h and then processed for TUNEL staining following the manufacturer's protocol (Chemicon). Briefly, cells were washed twice in PBS and fixed in 1% paraformaldehyde in PBS for 10 min at room temperature. Cells were washed twice in PBS and incubated in 2:1 mixture of ethanol/acetic acid at −20°C for 5 min. Cells were washed twice in PBS and incubated in equilibration buffer for 10 s immediately followed by incubation with working strength terminal deoxyribonucleotide transferase enzyme for 1 h in a humidified chamber at 37°C. Cells were then incubated in Working Strength Stop/Wash Buffer for 10 min at room temperature. Slides were mounted using Vectashield mounting medium containing 4′,6-diamidino-2-phenylindole (Vector Labs). Data were quantified by counting TUNEL-positive cells and analyzed by Student's t test.

Acknowledgments

We thank Drs. Jacqueline Emrich and Jay Reiff and other members of the Radiation Oncology Department for assistance with cell irradiation; Kathy Lengel for technical assistance; and Andrew Ippolito and other members of the Clifford laboratory for helpful discussions and comments on the manuscript.

Footnotes

  • ↵1 http://prospector.ucsf.edu

  • Grant support: NIH CA91681 and the W.W. Smith Charitable Trust (J. Azizkhan-Clifford).

  • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • Note: B.A. Olofsson and C.M. Kelly contributed equally to this work.

    • Accepted October 11, 2007.
    • Received August 8, 2007.
    • Revision received October 9, 2007.
  • American Association for Cancer Research

References

  1. ↵
    Dynan WS, Tjian R. The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell 1983;35:79–87.
    OpenUrlCrossRefPubMed
  2. Jones KA, Tjian R. Sp1 binds to promoter sequences and activates herpes simplex virus ‘immediate-early’ gene transcription in vitro. Nature 1985;317:179–82.
    OpenUrlCrossRefPubMed
  3. ↵
    Kadonaga JT, Carner KR, Masiarz FR, Tjian R. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell 1987;51:1079–90.
    OpenUrlCrossRefPubMed
  4. ↵
    Marin M, Karis A, Visser P, Grosveld F, Philipsen S. Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation. Cell 1997;89:619–28.
    OpenUrlCrossRefPubMed
  5. ↵
    Saffer JD, Jackson SP, Annarella MB. Developmental expression of Sp1 in the mouse. Mol Cell Biol 1991;11:2189–99.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Gidoni D, Dynan WS, Tjian R. Multiple specific contacts between a mammalian transcription factor and its cognate promoters. Nature 1984;312:409–13.
    OpenUrlCrossRefPubMed
  7. Gidoni D, Kadonaga JT, Barrera-Saldana H, Takahashi K, Chambon P, Tjian R. Bidirectional SV40 transcription mediated by tandem Sp1 binding interactions. Science 1985;230:511–7.
    OpenUrlAbstract/FREE Full Text
  8. Hoey T, Weinzierl RO, Gill G, Chen JL, Dynlacht BD, Tjian R. Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators. Cell 1993;72:247–60.
    OpenUrlCrossRefPubMed
  9. ↵
    Tanese N, Saluja D, Vassallo MF, Chen JL, Admon A. Molecular cloning and analysis of two subunits of the human TFIID complex: hTAFII130 and hTAFII100. Proc Natl Acad Sci U S A 1996;93:13611–6.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Yang C, Bolotin E, Jiang T, Sladek FM, Martinez E. Prevalence of the initiator over the TATA box in human and yeast genes and identification of DNA motifs enriched in human TATA-less core promoters. Gene 2007;389:52–65.
    OpenUrlCrossRefPubMed
  11. ↵
    Jackson SP, MacDonald JJ, Lees-Miller S, Tjian R. GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase. Cell 1990;63:155–65.
    OpenUrlCrossRefPubMed
  12. Jackson SP, Tjian R. O-glycosylation of eukaryotic transcription factors: implications for mechanisms of transcriptional regulation. Cell 1988;55:125–33.
    OpenUrlPubMed
  13. ↵
    Spengler ML, Brattain MG. Sumoylation inhibits cleavage of Sp1 N-terminal negative regulatory domain and inhibits Sp1-dependent transcription. J Biol Chem 2006;281:5567–74.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    Armstrong SA, Barry DA, Leggett RW, Mueller CR. Casein kinase II-mediated phosphorylation of the C terminus of Sp1 decreases its DNA binding activity. J Biol Chem 1997;272:13489–95.
    OpenUrlAbstract/FREE Full Text
  15. Fojas de Borja P, Collins NK, Du P, Azizkhan-Clifford J, Mudryj M. Cyclin A-CDK phosphorylates Sp1 and enhances Sp1-mediated transcription. EMBO J 2001;20:5737–47.
    OpenUrlAbstract
  16. ↵
    Ryu H, Lee J, Zaman K, et al. Sp1 and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neurons. J Neurosci 2003;23:3597–606.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    Black AR, Black JD, Azizkhan-Clifford J. Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 2001;188:143–60.
    OpenUrlCrossRefPubMed
  18. ↵
    Li L, He S, Sun JM, Davie JR. Gene regulation by Sp1 and Sp3. Biochem Cell Biol 2004;82:460–71.
    OpenUrlCrossRefPubMed
  19. ↵
    Black AR, Jensen D, Lin SY, Azizkhan JC. Growth/cell cycle regulation of Sp1 phosphorylation. J Biol Chem 1999;274:1207–15.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Kim DB, DeLuca NA. Phosphorylation of transcription factor Sp1 during herpes simplex virus type 1 infection. J Virol 2002;76:6473–9.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    Meighan-Mantha RL, Riegel AT, Suy S, et al. Ionizing radiation stimulates octamer factor DNA binding activity in human carcinoma cells. Mol Cell Biochem 1999;199:209–15.
    OpenUrlCrossRefPubMed
  22. ↵
    Yang CR, Wilson-Van Patten C, Planchon SM, et al. Coordinate modulation of Sp1, NF-κB, and p53 in confluent human malignant melanoma cells after ionizing radiation. FASEB J 2000;14:379–90.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    Ryu H, Lee J, Olofsson BA, et al. Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway. Proc Natl Acad Sci U S A 2003;100:4281–6.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Evans MD, Dizdaroglu M, Cooke MS. Oxidative DNA damage and disease: induction, repair and significance. Mutat Res 2004;567:1–61.
    OpenUrlCrossRefPubMed
  25. ↵
    Roberfroid M, Calderon PB. Free radicals and oxidation phenomena in biological systems. New York: Marcel Dekker, Inc.; 1995.
  26. ↵
    Shiloh Y. The ATM-mediated DNA-damage response: taking shape. Trends Biochem Sci 2006;31:402–10.
    OpenUrlCrossRefPubMed
  27. ↵
    Abraham RT. PI3-kinase related kinases: ‘big’ players in stress-induced signaling pathways. DNA Repair (Amst) 2004;3:883–7.
    OpenUrlCrossRefPubMed
  28. ↵
    Shiloh Y, Kastan MB. ATM: genome stability, neuronal development, and cancer cross paths. Adv Cancer Res 2001;83:209–54.
    OpenUrlPubMed
  29. ↵
    Siliciano JD, Canman CE, Taya Y, Sakaguchi K, Appella E, Kastan MB. DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev 1997;11:3471–81.
    OpenUrlAbstract/FREE Full Text
  30. ↵
    Cortez D, Wang Y, Qin J, Elledge SJ. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. Science 1999;286:1162–6.
    OpenUrlAbstract/FREE Full Text
  31. ↵
    Bhoumik A, Takahashi S, Breitweiser W, Shiloh Y, Jones N, Ronai Z. ATM-dependent phosphorylation of ATF2 is required for the DNA damage response. Mol Cell 2005;18:577–87.
    OpenUrlCrossRefPubMed
  32. ↵
    Shi Y, Venkataraman SL, Dodson GE, Mabb AM, LeBlanc S, Tibbetts RS. Direct regulation of CREB transcriptional activity by ATM in response to genotoxic stress. Proc Natl Acad Sci U S A 2004;101:5898–903.
    OpenUrlAbstract/FREE Full Text
  33. ↵
    Lin WC, Lin FT, Nevins JR. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev 2001;15:1833–44.
    OpenUrlAbstract/FREE Full Text
  34. ↵
    Wu ZH, Shi Y, Tibbetts RS, Miyamoto S. Molecular linkage between the kinase ATM and NF-κB signaling in response to genotoxic stimuli. Science 2006;311:1141–6.
    OpenUrlAbstract/FREE Full Text
  35. ↵
    Rogakou EP, Boon C, Redon C, Bonner WM. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J Cell Biol 1999;146:905–16.
    OpenUrlAbstract/FREE Full Text
  36. ↵
    Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998;273:5858–68.
    OpenUrlAbstract/FREE Full Text
  37. ↵
    Heinloth AN, Shackelford RE, Innes CL, et al. ATM-dependent and -independent gene expression changes in response to oxidative stress, γ irradiation, and UV irradiation. Radiat Res 2003;160:273–90.
    OpenUrlCrossRefPubMed
  38. ↵
    Shahrabani-Gargir L, Pandita TK, Werner H. Ataxia-telangiectasia mutated gene controls insulin-like growth factor I receptor gene expression in a deoxyribonucleic acid damage response pathway via mechanisms involving zinc-finger transcription factors Sp1 and WT1. Endocrinology 2004;145:5679–87.
    OpenUrlCrossRefPubMed
  39. ↵
    Traven A, Heierhorst J. SQ/TQ cluster domains: concentrated ATM/ATR kinase phosphorylation site regions in DNA-damage-response proteins. Bioessays 2005;27:397–407.
    OpenUrlCrossRefPubMed
  40. ↵
    Kim ST, Lim DS, Canman CE, Kastan MB. Substrate specificities and identification of putative substrates of ATM kinase family members. J Biol Chem 1999;274:37538–43.
    OpenUrlAbstract/FREE Full Text
  41. ↵
    O'Neill T, Dwyer AJ, Ziv Y, et al. Utilization of oriented peptide libraries to identify substrate motifs selected by ATM. J Biol Chem 2000;275:22719–27.
    OpenUrlAbstract/FREE Full Text
  42. ↵
    Courey AJ, Tjian R. Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell 1988;55:887–98.
    OpenUrlCrossRefPubMed
  43. ↵
    Rothkamm K, Lobrich M. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low X-ray doses. Proc Natl Acad Sci U S A 2003;100:5057–62.
    OpenUrlAbstract/FREE Full Text
  44. ↵
    Sedelnikova OA, Rogakou EP, Panyutin IG, Bonner WM. Quantitative detection of (125)IdU-induced DNA double-strand breaks with γ-H2AX antibody. Radiat Res 2002;158:486–92.
    OpenUrlCrossRefPubMed
  45. ↵
    Tibbetts RS, Brumbaugh KM, Williams JM, et al. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev 1999;13:152–7.
    OpenUrlAbstract/FREE Full Text
  46. ↵
    Hickson I, Zhao Y, Richardson CJ, et al. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res 2004;64:9152–9.
    OpenUrlAbstract/FREE Full Text
  47. ↵
    Chu S, Ferro TJ. Sp1: Regulation of gene expression by phosphorylation. Gene 2005;348:1–11.
    OpenUrlCrossRefPubMed
  48. ↵
    Kundu TK, Rao MR. CpG islands in chromatin organization and gene expression. J Biochem (Tokyo) 1999;125:217–22.
    OpenUrlAbstract/FREE Full Text
  49. Mattes WB, Hartley JA, Kohn KW, Matheson DW. GC-rich regions in genomes as targets for DNA alkylation. Carcinogenesis 1988;9:2065–72.
    OpenUrlAbstract/FREE Full Text
  50. Pfeiffer P, Goedecke W, Obe G. Mechanisms of DNA double-strand break repair and their potential to induce chromosomal aberrations. Mutagenesis 2000;15:289–302.
    OpenUrlAbstract/FREE Full Text
  51. ↵
    Surralles J, Ramirez MJ, Marcos R, Natarajan AT, Mullenders LH. Clusters of transcription-coupled repair in the human genome. Proc Natl Acad Sci U S A 2002;99:10571–4.
    OpenUrlAbstract/FREE Full Text
  52. ↵
    Kaczynski J, Cook T, Urrutia R. Sp1- and Kruppel-like transcription factors. Genome Biol 2003;4:206.
    OpenUrlCrossRefPubMed
  53. Sogawa K, Kikuchi Y, Imataka H, Fujii-Kuriyama Y. Comparison of DNA-binding properties between BTEB and Sp1. J Biochem (Tokyo) 1993;114:605–9.
    OpenUrlAbstract/FREE Full Text
  54. ↵
    Suske G. The Sp-family of transcription factors. Gene 1999;238:291–300.
    OpenUrlCrossRefPubMed
  55. ↵
    Niina I, Uchiumi T, Izumi H, et al. DNA topoisomerase inhibitor, etoposide, enhances GC-box-dependent promoter activity via Sp1 phosphorylation. Cancer Sci 2007;98:858–63.
    OpenUrlCrossRefPubMed
  56. ↵
    Matsuoka S, Ballif BA, Smogorzewska A, et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007;316:1160–6.
    OpenUrlAbstract/FREE Full Text
  57. Rotman G, Shiloh Y. ATM: a mediator of multiple responses to genotoxic stress. Oncogene 1999;18:6135–44.
    OpenUrlCrossRefPubMed
  58. Taylor AM, Harnden DG, Arlett CF, et al. Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature 1975;258:427–9.
    OpenUrlCrossRefPubMed
  59. ↵
    Fedier A, Schlamminger M, Schwarz VA, Haller U, Howell SB, Fink D. Loss of ATM sensitises p53-deficient cells to topoisomerase poisons and antimetabolites. Ann Oncol 2003;14:938–45.
    OpenUrlAbstract/FREE Full Text
  60. ↵
    Fedier A, Steiner RA, Schwarz VA, Lenherr L, Haller U, Fink D. The effect of loss of Brca1 on the sensitivity to anticancer agents in p53-deficient cells. Int J Oncol 2003;22:1169–73.
    OpenUrlPubMed
  61. Blasiak J, Arabski M, Krupa R, et al. Basal, oxidative and alkylative DNA damage, DNA repair efficacy and mutagen sensitivity in breast cancer. Mutat Res 2004;554:139–48.
    OpenUrlCrossRefPubMed
  62. Kang J, Bronson RT, Xu Y. Targeted disruption of NBS1 reveals its roles in mouse development and DNA repair. EMBO J 2002;21:1447–55.
    OpenUrlAbstract
  63. Quinn JE, Kennedy RD, Mullan PB, et al. BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis. Cancer Res 2003;63:6221–8.
    OpenUrlAbstract/FREE Full Text
  64. Sgagias MK, Wagner KU, Hamik B, et al. Brca1-deficient murine mammary epithelial cells have increased sensitivity to CDDP and MMS. Cell Cycle 2004;3:1451–6.
    OpenUrlPubMed
  65. Shiloh Y. Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. Annu Rev Genet 1997;31:635–62.
    OpenUrlCrossRefPubMed
  66. ↵
    Yamaguchi-Iwai Y, Sonoda E, Sasaki MS, et al. Mre11 is essential for the maintenance of chromosomal DNA in vertebrate cells. EMBO J 1999;18:6619–29.
    OpenUrlAbstract
  67. ↵
    Elkon R, Rashi-Elkeles S, Lerenthal Y, et al. Dissection of a DNA-damage-induced transcriptional network using a combination of microarrays, RNA interference and computational promoter analysis. Genome Biol 2005;6:R43.
    OpenUrlCrossRefPubMed
  68. Rashi-Elkeles S, Elkon R, Weizman N, et al. Parallel induction of ATM-dependent pro- and antiapoptotic signals in response to ionizing radiation in murine lymphoid tissue. Oncogene 2006;25:1584–92.
    OpenUrlCrossRefPubMed
  69. ↵
    Stankovic T, Hubank M, Cronin D, et al. Microarray analysis reveals that TP53- and ATM-mutant B-CLLs share a defect in activating proapoptotic responses after DNA damage but are distinguished by major differences in activating prosurvival responses. Blood 2004;103:291–300.
    OpenUrlAbstract/FREE Full Text
  70. ↵
    Peretz S, Jensen R, Baserga R, Glazer PM. ATM-dependent expression of the insulin-like growth factor-I receptor in a pathway regulating radiation response. Proc Natl Acad Sci U S A 2001;98:1676–81.
    OpenUrlAbstract/FREE Full Text
  71. ↵
    Shi Y, Dodson GE, Shaikh S, Rundell K, Tibbetts RS. Ataxia-telangiectasia-mutated (ATM) is a T-antigen kinase that controls SV40 viral replication in vivo. J Biol Chem 2005;280:40195–200.
    OpenUrlAbstract/FREE Full Text
  72. ↵
    Shirata N, Kudoh A, Daikoku T, et al. Activation of ataxia telangiectasia-mutated DNA damage checkpoint signal transduction elicited by herpes simplex virus infection. J Biol Chem 2005;280:30336–41.
    OpenUrlAbstract/FREE Full Text
  73. ↵
    Iwahori S, Shirata N, Kawaguchi Y, et al. Enhanced phosphorylation of transcription factor Sp1 in response to herpes simplex virus type 1 infection is dependent on the ataxia telangiectasia-mutated protein. J Virol 2007;81:9653–64.
    OpenUrlAbstract/FREE Full Text
  74. ↵
    Mirzoeva OK, Petrini JH. DNA damage-dependent nuclear dynamics of the Mre11 complex. Mol Cell Biol 2001;21:281–8.
    OpenUrlAbstract/FREE Full Text
  75. ↵
    Kodym R, Horth E. Determination of radiation-induced DNA strand breaks in individual cells by non-radioactive labelling of 3′ OH ends. Int J Radiat Biol 1995;68:133–9.
    OpenUrlCrossRefPubMed
  76. ↵
    Pascal E, Tjian R. Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism. Genes Dev 1991;5:1646–56.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Molecular Cancer Research: 5 (12)
December 2007
Volume 5, Issue 12
  • Table of Contents
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Phosphorylation of Sp1 in Response to DNA Damage by Ataxia Telangiectasia-Mutated Kinase
(Your Name) has forwarded a page to you from Molecular Cancer Research
(Your Name) thought you would be interested in this article in Molecular Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Phosphorylation of Sp1 in Response to DNA Damage by Ataxia Telangiectasia-Mutated Kinase
Beatrix A. Olofsson, Crystal M. Kelly, Jiyoon Kim, Stephen M. Hornsby and Jane Azizkhan-Clifford
Mol Cancer Res December 1 2007 (5) (12) 1319-1330; DOI: 10.1158/1541-7786.MCR-07-0374

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Phosphorylation of Sp1 in Response to DNA Damage by Ataxia Telangiectasia-Mutated Kinase
Beatrix A. Olofsson, Crystal M. Kelly, Jiyoon Kim, Stephen M. Hornsby and Jane Azizkhan-Clifford
Mol Cancer Res December 1 2007 (5) (12) 1319-1330; DOI: 10.1158/1541-7786.MCR-07-0374
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Materials and Methods
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • A Cross-species Alkylation Functionome
  • Radiation-Induced EGFR-DNA-PKcs Interactions
  • Suberoylanilide Hydroxamic Acid Inhibits Homolog-Directed Repair
Show more DNA Damage and Cellular Stress Responses
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Rapid Impact Archive
  • Meeting Abstracts

Information for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCR

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Research
eISSN: 1557-3125
ISSN: 1541-7786

Advertisement